{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:10:33Z","timestamp":1794651033955,"version":"4.9.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Papillary thyroid carcinoma (PTC) is the predominant form of thyroid cancer globally, especially when lymph node metastasis (LNM) occurs. Molecular heterogeneity, driven by genetic alterations and tumor microenvironment components, contributes to the complexity of PTC. Understanding these complexities is essential for precise risk stratification and therapeutic decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study involved a comprehensive analysis of 521 patients with PTC from our hospital and 499 patients from The Cancer Genome Atlas (TCGA). The real-world cohort 1 comprised 256 patients with stage I\u2013III PTC. Tissues from 252 patients were analyzed by DNA-based next-generation sequencing, and tissues from four patients were analyzed by single-cell RNA sequencing (scRNA-seq). Additionally, 586 PTC pathological sections were collected from TCGA, and 275 PTC pathological sections were collected from the real-world cohort 2. A deep-learning multi-modal model was developed using matched histopathology images, genomic, transcriptomic, and immune cell data to predict LNM and disease-free survival (DFS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      This study included a total of 1011 PTC patients, comprising 256 patients from cohort 1, 275 patients from cohort 2, and 499 patients from TCGA. In cohort 1, the authors categorized PTC into four molecular subtypes based on BRAF, RAS, RET, and other mutations. BRAF mutations were significantly associated with LNM and impacted DFS. ScRNA-seq identified distinct T-cell subtypes and reduced B-cell diversity in BRAF-mutated PTC with LNM. The study also explored cancer-associated fibroblasts and macrophages, highlighting their associations with LNM. The deep-learning model was trained using 405 pathology slides and RNA sequences from 328 PTC patients and validated with 181 slides and RNA sequences from 140 PTC patients in the TCGA cohort. It achieved high accuracy, with an area under the curve (AUC) of 0.86 in the training cohort, 0.84 in the validation cohort, and 0.83 in the real-world cohort 2. High-risk patients in the training cohort had significantly lower DFS rates (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). Model AUCs were 0.91 at 1 year, 0.93 at 3 years, and 0.87 at 5 years. In the validation cohort, high-risk patients also had lower DFS (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001); the AUCs were 0.89, 0.87, and 0.80 at 1, 3, and 5 years. The authors utilized the GradCAM algorithm to generate heatmaps from pathology-based deep-learning models, which visually highlighted high-risk tumor areas in PTC patients. This enhanced clinicians\u2019 understanding of the model\u2019s predictions and improved diagnostic accuracy, especially in cases with lymph node metastasis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The artificial intelligence (AI)-based analysis uncovered vital insights into PTC molecular heterogeneity, emphasizing BRAF mutations\u2019 impact. The integrated deep-learning model shows promise in predicting metastasis, offering valuable contributions to improved diagnostic and therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000001875","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T12:05:50Z","timestamp":1720699550000},"page":"839-856","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":54,"title":["Artificial intelligence-based multi-modal multi-tasks analysis reveals tumor molecular heterogeneity, predicts preoperative lymph node metastasis and prognosis in papillary thyroid carcinoma: a retrospective study"],"prefix":"10.1097","volume":"111","author":[{"given":"Yunfang","family":"Yu","sequence":"first","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Thyroid Surgery, Department of Medical Oncology, Breast Tumor Centre, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China"},{"name":"Faculty of Medicine, Macau University of Science and Technology, Taipa, Macao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Thyroid Surgery, Department of Medical Oncology, Breast Tumor Centre, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxi","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Experimental Research, The Affiliated Tumor Hospital of Guangxi Medical University, Xi Guang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Huang","sequence":"additional","affiliation":[{"name":"Guilin Medical University, Xi Guang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehua","family":"Wang","sequence":"additional","affiliation":[{"name":"Faculty of Innovation Engineering, Macau University of Science and Technology, Taipa, Macao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyuan","family":"Jia","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Macau University of Science and Technology, Taipa, Macao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjun","family":"Huang","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Thyroid Surgery, Department of Medical Oncology, Breast Tumor Centre, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruichong","family":"Lin","sequence":"additional","affiliation":[{"name":"Faculty of Innovation Engineering, Macau University of Science and Technology, Taipa, Macao, China"},{"name":"School of Computer Engineering, Guangzhou Huali College, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhu","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Thyroid Surgery, Department of Medical Oncology, Breast Tumor Centre, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisitandaer","family":"yalikun","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Thyroid Surgery, Department of Medical Oncology, Breast Tumor Centre, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Langping","family":"Tan","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Thyroid Surgery, Department of Medical Oncology, Breast Tumor Centre, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[{"name":"Burning Rock Biotech, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Burning Rock Biotech, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhange","family":"Chen","sequence":"additional","affiliation":[{"name":"Faculty of Innovation Engineering, Macau University of Science and Technology, Taipa, Macao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Li","sequence":"additional","affiliation":[{"name":"Singleron Biotechnologies, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Liao","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Diagnostics Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herui","family":"Yao","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Thyroid Surgery, Department of Medical Oncology, Breast Tumor Centre, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoyun","family":"Long","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Thyroid Surgery, Department of Medical Oncology, Breast Tumor Centre, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1]]},"reference":[{"key":"R1-20260304","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R2-20260304","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/RLU.0000000000004468","article-title":"Metastatic papillary thyroid cancer mimicking hypopharyngeal carcinoma","volume":"48","author":"Du","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R3-20260304","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/cen.14361","article-title":"Ultrasonography-guided radiofrequency ablation vs. surgery for the treatment of solitary T1bN0M0 papillary thyroid carcinoma: a comparative study","volume":"94","author":"Xiao","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R4-20260304","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3390\/cancers12020383","article-title":"Intratumoral genetic heterogeneity in papillary thyroid cancer: occurrence and clinical significance","volume":"12","author":"Fugazzola","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R5-20260304","doi-asserted-by":"crossref","first-page":"e230581","DOI":"10.1148\/radiol.230581","article-title":"Perfluorobutane-enhanced US helps differentiate benign lymph nodes from papillary thyroid cancer metastases","volume":"307","author":"Gunabushanam","year":"2023","journal-title":"Radiology"},{"key":"R6-20260304","doi-asserted-by":"crossref","first-page":"816897","DOI":"10.3389\/fonc.2022.816897","article-title":"Genotypes of papillary thyroid carcinoma with high lateral neck metastasis in chinese population","volume":"12","author":"Guo","year":"2022","journal-title":"Front Oncol"},{"key":"R7-20260304","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/s41467-022-29000-5","article-title":"Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"key":"R8-20260304","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1038\/s41388-022-02254-5","article-title":"Integrative metabolomic characterization identifies plasma metabolomic signature in the diagnosis of papillary thyroid cancer","volume":"41","author":"Yu","year":"2022","journal-title":"Oncogene"},{"issue":"Pt 1","key":"R9-20260304","doi-asserted-by":"crossref","first-page":"137162","DOI":"10.1016\/j.chemosphere.2022.137162","article-title":"A case-control study of urinary concentrations of bisphenol A, bisphenol F, and bisphenol S and the risk of papillary thyroid cancer","volume":"312","author":"Zhang","year":"2023","journal-title":"Chemosphere"},{"key":"R10-20260304","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/s41467-021-26343-3","article-title":"Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma","volume":"12","author":"Pu","year":"2021","journal-title":"Nat Commun"},{"key":"R11-20260304","doi-asserted-by":"crossref","first-page":"e228722","DOI":"10.1001\/jamanetworkopen.2022.8722","article-title":"Physician perspectives of overdiagnosis and overtreatment of low-risk papillary thyroid cancer in the US","volume":"5","author":"Dedhia","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R12-20260304","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s12276-022-00740-0","article-title":"Dissection of molecular and histological subtypes of papillary thyroid cancer using alternative splicing profiles","volume":"54","author":"Park","year":"2022","journal-title":"Exp Mol Med"},{"key":"R13-20260304","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41392-021-00729-7","article-title":"Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence","volume":"6","author":"Xu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"R14-20260304","doi-asserted-by":"crossref","first-page":"106165","DOI":"10.1016\/j.ijsu.2021.106165","article-title":"STROCSS 2021: Strengthening the Reporting of cohort, cross-sectional and case-control studies in Surgery","volume":"96","author":"Mathew","year":"2021","journal-title":"Int J Surg"},{"key":"R15-20260304","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41551-020-00682-w","article-title":"Data-efficient and weakly supervised computational pathology on whole-slide images","volume":"5","author":"Lu","year":"2021","journal-title":"Nat Biomed Eng"},{"issue":"Pt C","key":"R16-20260304","doi-asserted-by":"crossref","first-page":"113367","DOI":"10.1016\/j.envres.2022.113367","article-title":"A nested case-control study of serum polychlorinated biphenyls and papillary thyroid cancer risk among U.S. military service members","volume":"212","author":"Zhuo","year":"2022","journal-title":"Environ Res"},{"key":"R17-20260304","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41586-021-03512-4","article-title":"AI-based pathology predicts origins for cancers of unknown primary","volume":"594","author":"Lu","year":"2021","journal-title":"Nature"},{"key":"R18-20260304","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamaoto.2021.2359","article-title":"Thyroid lobectomy for T1 papillary thyroid carcinoma in pediatric patients","volume":"147","author":"Sudoko","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R19-20260304","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1172\/JCI126022","article-title":"IL-6\/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion","volume":"129","author":"Chan","year":"2019","journal-title":"J Clin Invest"},{"key":"R20-20260304","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41565-021-01032-w","article-title":"Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion","volume":"17","author":"Liu","year":"2022","journal-title":"Nat Nanotechnol"},{"key":"R21-20260304","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1038\/s41467-019-12771-9","article-title":"Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy","volume":"10","author":"Huang","year":"2019","journal-title":"Nat Commun"},{"key":"R22-20260304","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1210\/clinem\/dgab286","article-title":"BRAF V600E status sharply differentiates lymph node metastasis-associated mortality risk in papillary thyroid cancer","volume":"106","author":"Tao","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-20260304","doi-asserted-by":"crossref","first-page":"14072","DOI":"10.1021\/acsami.1c25179","article-title":"Charge reversal polypyrrole nanocomplex-mediated gene delivery and photothermal therapy for effectively treating papillary thyroid cancer and inhibiting lymphatic metastasis","volume":"14","author":"Xu","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"R24-20260304","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1158\/1078-0432.CCR-17-3705","article-title":"Copper chelation as targeted therapy in a mouse model of oncogenic BRAF-driven papillary thyroid cancer","volume":"24","author":"Xu","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R25-20260304","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/s41467-021-26343-3","article-title":"Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma","volume":"12","author":"Pu","year":"2021","journal-title":"Nat Commun"},{"key":"R26-20260304","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41416-018-0296-2","article-title":"Combinations of BRAF inhibitor and anti-PD-1\/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer","volume":"119","author":"Gunda","year":"2018","journal-title":"Br J Cancer"},{"key":"R27-20260304","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.ymthe.2021.01.019","article-title":"METTL3 restrains papillary thyroid cancer progression via m6A\/c-Rel\/IL-8-mediated neutrophil infiltration","volume":"29","author":"He","year":"2021","journal-title":"Mol Ther"},{"key":"R28-20260304","first-page":"djac178","article-title":"Fibroblast subsets in non-small cell lung cancer: associations with survival, mutations, and immune features","volume":"115","author":"Pellinen","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"R29-20260304","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","article-title":"Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer","volume":"13","author":"Qi","year":"2022","journal-title":"Nat Commun"},{"key":"R30-20260304","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol Cancer"},{"key":"R31-20260304","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/jmri.28695","article-title":"Deep learning with an attention mechanism for differentiating the origin of brain metastasis using MR images","volume":"58","author":"Jiao","year":"2023","journal-title":"J Magn Reson Imaging"},{"key":"R32-20260304","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/path.5864","article-title":"Computer-extracted features of nuclear morphology in hematoxylin and eosin images distinguish stage II and IV colon tumors","volume":"257","author":"Kumar","year":"2022","journal-title":"J Pathol"},{"key":"R33-20260304","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1002\/mef2.38","article-title":"Recent advances of transformers in medical image analysis: a comprehensive review","volume":"2","author":"Xia","year":"2023","journal-title":"MedComm Futur Med"},{"key":"R34-20260304","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1002\/mef2.43","article-title":"Accelerating the integration of ChatGPT and other large-scale AI models into biomedical research and healthcare","volume":"2","author":"Wang","year":"2023","journal-title":"MedComm \u2013 Future Med"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000001875","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:06:14Z","timestamp":1772625974000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000001875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,11]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000001875","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,11]]},"assertion":[{"value":"2024-04-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}